1. Home
  2. GDOT vs CERS Comparison

GDOT vs CERS Comparison

Compare GDOT & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDOT
  • CERS
  • Stock Information
  • Founded
  • GDOT 1999
  • CERS 1991
  • Country
  • GDOT United States
  • CERS United States
  • Employees
  • GDOT N/A
  • CERS N/A
  • Industry
  • GDOT Finance: Consumer Services
  • CERS EDP Services
  • Sector
  • GDOT Finance
  • CERS Technology
  • Exchange
  • GDOT Nasdaq
  • CERS Nasdaq
  • Market Cap
  • GDOT 363.9M
  • CERS 347.3M
  • IPO Year
  • GDOT 2010
  • CERS 1997
  • Fundamental
  • Price
  • GDOT $8.36
  • CERS $1.42
  • Analyst Decision
  • GDOT Hold
  • CERS Strong Buy
  • Analyst Count
  • GDOT 3
  • CERS 2
  • Target Price
  • GDOT $9.33
  • CERS $3.50
  • AVG Volume (30 Days)
  • GDOT 1.8M
  • CERS 1.6M
  • Earning Date
  • GDOT 05-08-2025
  • CERS 05-01-2025
  • Dividend Yield
  • GDOT N/A
  • CERS N/A
  • EPS Growth
  • GDOT N/A
  • CERS N/A
  • EPS
  • GDOT N/A
  • CERS N/A
  • Revenue
  • GDOT $1,718,370,000.00
  • CERS $180,270,000.00
  • Revenue This Year
  • GDOT $11.62
  • CERS $25.22
  • Revenue Next Year
  • GDOT $13.35
  • CERS $10.08
  • P/E Ratio
  • GDOT N/A
  • CERS N/A
  • Revenue Growth
  • GDOT 14.69
  • CERS 15.29
  • 52 Week Low
  • GDOT $6.12
  • CERS $1.38
  • 52 Week High
  • GDOT $13.58
  • CERS $2.54
  • Technical
  • Relative Strength Index (RSI)
  • GDOT 56.21
  • CERS 38.62
  • Support Level
  • GDOT $7.03
  • CERS $1.40
  • Resistance Level
  • GDOT $8.60
  • CERS $1.58
  • Average True Range (ATR)
  • GDOT 0.45
  • CERS 0.08
  • MACD
  • GDOT 0.21
  • CERS 0.00
  • Stochastic Oscillator
  • GDOT 90.32
  • CERS 19.05

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: